Bernard T Haylen ICS Chair
ELISABETTA COSTANTINI ICS Chair
16:30
#474 Introducing pelvic floor muscle training in weekly training sessions of young adult female athletes: a pilot study.
Presenter: Hedwig Neels
Neels H1, Roosens E2, Buley R2, Struyf F3, Aerenhouts D2, Vermandel A11. University of Antwerp, Faculty of Medicine and health Sciences, Revaki Movant, Antwerp University Hospital, 2. Vrije Universiteit Brussels, Belgium, 3. University of Antwerp, Faculty of Medicine and health Sciences, Revaki Movant Physiotherapy, Prevention, Pelvic Floor, Stress Urinary Incontinence, Female
16:37
#475 Factors related to the voiding pattern in women without voiding symptoms
Presenter: Juan Pablo Valdevenito
Valdevenito J P1, Mercado A1, Hernandez-Matas R M1, Alvarez D2, Kobus C2, Bull L21. Hospital Clinico Universidad de Chile, 2. Universidad de Chile Female, Voiding Dysfunction , Retrospective Study
16:45
#476 Validation of novel patient-applied surface electrode for treatment of female stress urinary incontinence
Presenter: Eric Kolb
Kolb E1, Kolb G11. Elidah, Inc. Stress Urinary Incontinence, Conservative Treatment, Female, Incontinence, New Devices
16:52
#477 COMPARISON BETWEEN TELEPHONE AND CONVENTIONAL OUTPATIENT CLINIC SETTING FOLLOW-UP IN WOMEN TREATED WITH MIDDLE URETHRAL SLING FOR STRESS URINARY INCONTINENCE
Presenter: Matteo Balzarro
Balzarro M1, Rubilotta E1, Trabacchin N1, Bassi S1, Cerruto M A1, Porcaro A B1, Artibani W11. AOUI Verona, dept. of Urology, Italy Stress Urinary Incontinence, Female, Surgery
17:00
#478 The relationship between activity behaviour and bladder dysfunction among older adults
Presenter: Joanne Booth
Ekström H1, Booth J1, Hagen S1, Skelton D11. Glasgow Caledonian University Incontinence, Urgency/Frequency, Stress Urinary Incontinence, Nocturia
17:07
#479 Higher urge severity scale predicts the recurrence of overactive bladder symptoms after discontinuing mirabegron in patients with overactive bladder
Presenter: Chung-Cheng Wang
Wang C1, Jiang Y2, Ong H2, Kuo H21. Department of Urology, En Chu Kong Hospital, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan Overactive Bladder, Quality of Life (QoL), Outcomes Research Methods
17:15
#480 Assessing residual bias within a real-world analysis a priori: A case study of cardiovascular (CV) risk profile in individuals treated for overactive bladder (OAB)
Presenter: Carol Schermer
Vonesh E1, Gooch K2, Khangulov V3, Schermer C2, Johnston K4, Szabo S4, Rumsfeld J51. Northwestern University, 2. Astellas Americas, 3. Boston Strategic Partners, 4. Broadstreet HEOR, 5. University of Colorado Mathematical or statistical modelling, Outcomes Research Methods, Overactive Bladder
17:22
#481 Comparison of healthcare costs and resource utilization for overactive bladder patients in the United States persisting with mirabegron treatment or switching to onabotulinumtoxin A
Presenter: Daniel Bin Ng
Ng D B1, Espinosa R2, Johnson S2, Walker D1, Gooch K11. Astellas Pharma Global Development, 2. Medicus Economics LLC Overactive Bladder, Retrospective Study, Detrusor Overactivity